Completed PHASE4 INTERVENTIONAL 2-arm NCT00925288

Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers (Girasol)

Acceptability and Feasibility of a Modified HPV Vaccine Schedule in Brothel Based Female Sex Workers in Peru

Sponsor: Johns Hopkins Bloomberg School of Public Health

Conditions Human Papillomavirus Infection

Interventions Gardasil

Updated 7 times since 2017 Last updated: Sep 10, 2012 Started: Oct 31, 2009 Primary completion: Aug 31, 2011 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Human Papillomavirus Infection, this trial is completed. The trial is conducted by Johns Hopkins Bloomberg School of Public Health and has accumulated 7 data snapshots since 2009. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jun 2022 — Jul 2024 [monthly]

Completed PHASE4
Dec 2021 — Jun 2022 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johns Hopkins Bloomberg School of Public Health
Merck Sharp & Dohme LLC
NGO Via Libre
Universidad Peruana Cayetano Heredia

Data source: Johns Hopkins Bloomberg School of Public Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lima, Peru